ClassID:

95332

C07D455/02 - CPC Classification

Classification description:

Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems

Recent Application in this class:
#1
20260001838
2026-01-01

NANOMATERIALS

#2
20240343742
2024-10-17

VINYL IMIDAZOLE COMPOUNDS AS INHIBITORS OF KRAS

#3
20240287063
2024-08-29

METHIONINE ADENOSYLTRANSFERASE 2A INHIBITOR

#4
20240199609
2024-06-20

COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2

#5
20230339856
2023-10-26

NOVEL PHARMACOLOGICAL CHAPERONE COMPOUNDS OF HUMAN ACID ALPHA-GLUCOSIDASE AND THE THERAPEUTIC USE THEREOF

#6
20230167058
2023-06-01

GPX4 COMPOUNDS AND COMPOSITIONS AND METHODS OF TREATMENT USING SAME

#7
20230145481
2023-05-11

SUBSTITUTED BENZENECARBOXAMIDES AS IL-17A MODULATORS

#8
20230141212
2023-05-11

SUBSTITUTED BENZENECARBOXAMIDES AS IL-17A MODULATORS

#9
20230104155
2023-04-06

Isoquinolin-3-yl carboxamides and preparation and use thereof

#10
20230099441
2023-03-30

HETEROCYCLIC COMPOUND, APPLICATION THEREOF, AND COMPOSITION CONTAINING SAME

#11
20230053746
2023-02-23

IL-17 ligands and uses thereof

#12
20230042358
2023-02-09

Heterocyclic compound

#13
20220235038
2022-07-28

SUBSTITUTED BENZENECARBOXAMIDES AS IL-17A MODULATORS

#14
20220119381
2022-04-21

Composition for inhibiting growth of SARS-CoV-2 and method of preparing the same

#15
20220064188
2022-03-03

Vinyl imidazole compounds as inhibitors of KRAS

#16
20220064157
2022-03-03

High penetration drugs and their compositions thereof for treatment of Parkinson diseases

#17
20210300919
2021-09-30

Compounds and compositions for inhibiting the activity of SHP2

#18
20210261557
2021-08-26

GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

#19
20210230112
2021-07-29

NANOMATERIALS

#20
20210101886
2021-04-08

Substituted benzenecarboxamides as IL-17A modulators

#21
20200339536
2020-10-29

Isoquinolin-3-yl carboxamides and preparation and use thereof

#22
20200247785
2020-08-06

IL-17 ligands and uses thereof

#23
20200048266
2020-02-13

GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

#24
20200002330
2020-01-02

Compounds and compositions for inhibiting the activity of SHP2

#25
20190185637
2019-06-20

Films and unit dose articles comprising aversive UV-protective agents, and uses and methods related thereto

#26
20190105367
2019-04-11

ANTIMICROBIAL 4-OXOQUINOLIZINES

#27
20180296555
2018-10-18

2-pyridone antimicrobial compositions

#28
20180222887
2018-08-09

Isoquinolin-3-YL carboxamides and preparation and use thereof

#29
20180208580
2018-07-26

Isoquinolin-3-yl carboxamides and preparation and use thereof

#30
20180028509
2018-02-01

Substituted quinolizine derivatives useful as HIV integrase inhibitors

#31
20170334908
2017-11-23

High penetration drugs and their compositions thereof for treatment of Parkinson diseases

#32
20170313681
2017-11-02

Isoquinolin-3-yl carboxamides and preparation and use thereof

#33
20170107202
2017-04-20

Compounds useful as immunomodulators

#34
20170106045
2017-04-20

Antimicrobial 4-oxoquinolizines

#35
20160228419
2016-08-11

Substituted quinolizine derivatives useful as HIV integrase inhibitors

#36
20160207933
2016-07-21

GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

#37
20160068494
2016-03-10

Fused heterocyclic or carbocyclic compounds carrying a substituted cycloaliphatic radical and use thereof for treating vasopressin-related diseases

#38
20160002157
2016-01-07

High penetration drugs and their compositions thereof for treatment of parkinson diseases

#39
20150353570
2015-12-10

Substituted benzamides and substituted pyridinecarboxamides as Btk inhibitors

#40
20150306100
2015-10-29

Protein kinase C inhibitors and uses thereof

#41
20150175562
2015-06-25

Carboxamide or sulfonamide substituted thiazoles and related derivatives as modulators for the orphan nuclear receptor ROR[γ]

#42
20150141435
2015-05-21

2-PYRIDONE ANTIMICROBIAL COMPOSITIONS

#43
20150072952
2015-03-12

Glycomimetics to inhibit pathogen-host interactions

#44
20140336378
2014-11-13

Benzamide derivative and use thereof

#45
20140206681
2014-07-24

BTK INHIBITORS

#46
20140163022
2014-06-12

Protein kinase C inhibitors and uses thereof

#47
20140094450
2014-04-03

Benzoimidazole-carboxylic acid amide derivatives as APJ receptor modulators

#48
20140038955
2014-02-06

HETEROARYL AMIDE ANALOGUES AS P2X7 ANTAGONISTS

#49
20140030191
2014-01-30

1,4-disubstituted 1,2,3-triazoles, methods for preparing same, and diagnostic and therapeutic uses thereof

#50
20130310357
2013-11-21

Azolyl urea compounds and methods of use thereof

#51
20130252882
2013-09-26

Antimicrobial 4-oxoquinolizines

#52
20130245035
2013-09-19

2-pyridone antimicrobial compositions

#53
20130172335
2013-07-04

2,3-DIARYL- OR HETEROARYL-SUBSTITUTED 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS

#54
20120232071
2012-09-13

2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds

#55
20120122834
2012-05-17

Small molecule CD4 mimetics and uses thereof

#56
20110313165
2011-12-22

Quinolizidine and indolizidine derivatives

#57
20110301192
2011-12-08

Inhibitors of Cyclin Kinase Inhibitor p21

#58
20110206609
2011-08-25

Fluoroalkyl tetrabenazine carbinol compounds as imaging agents and probes

#59
20110178122
2011-07-21

Quinolizidinone M1 receptor positive allosteric modulators

#60
20110112077
2011-05-12

Quinolizidinone M1 receptor positive allosteric modulators

#61
20110110890
2011-05-12

Novel Inhibitors of Hepatitis C Virus Replication

#62
20110046145
2011-02-24

Quinolizidinone M1 receptor positive allosteric modulators

#63
20110015201
2011-01-20

Hedgehog pathway antagonists methods of use

#64
20110015180
2011-01-20

Chemokine receptor antagonists

#65
20110003808
2011-01-06

OCTAHYDROQUINOLIZINES FOR ANTIDIABETIC TREATMENT

#66
20100324024
2010-12-23

Quinolizidinone M1 receptor positive allosteric modulators

#67
20100298372
2010-11-25

GAMMA SECRETASE MODULATORS

#68
20100266509
2010-10-21

Heteroaryl amide analogues as P2Xantagonists

#69
20100249124
2010-09-30

2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds

#70
20100222355
2010-09-02

Quinolizidinone M1 receptor positive allosteric modulators

#71
20100137230
2010-06-03

NEW PYRIDIN-2-ONE COMPOUNDS

#72
20100081686
2010-04-01

Pyridone derivatives having a binding activity to the cannabinoid type 2 receptor

#73
20090197863
2009-08-06

Benzoxazole carboxamide inhibitors of poly(ADP-ribose)polymerase (PARP)

#74
20090105259
2009-04-23

Acyclic 1,4-Diamines and Uses Thereof

#75
20090088436
2009-04-02

P38 Kinase Inhibiting Agents

#76
20090030207
2009-01-29

Polymorphs of Dolasetron base and process for preparation thereof

#77
20080262031
2008-10-23

4-Aminoquinoline Derivatives as Antimalarials

#78
20080176860
2008-07-24

PYRIDIN-2-ONE COMPOUNDS

#79
20070179165
2007-08-02

Cyclic compounds

#80
20070155721
2007-07-05

Chemokine receptor antagonists

#81
20070129372
2007-06-07

P38 kinase inhibiting agents

#82
20060128756
2006-06-15

Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses

#83
20060084665
2006-04-20

Quinolizinone compound and use thereof as HIV integrase inhibitor

#84
20060052411
2006-03-09

Pyridone derivatives having a binding activity to the cannabinoid type 2 receptor

#85
20060041095
2006-02-23

Intermediate products, methods for their preparation and use thereof

#86
20060019986
2006-01-26

(R/S) rifamycin derivatives, their preparations and pharmaceutical compositions

#87
20060019985
2006-01-26

Rifamycin derivatives

#88
20050283006
2005-12-22

Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses

#89
20050256089
2005-11-17

Phenyl-substituted 4-hydroxy-tetrahydropyridones

#90
20050159444
2005-07-21

Bicyclic unsaturated tertiary amine compounds

#91
20050032792
2005-02-10

Compounds useful as reversible inhibitors of cysteine proteases

#92
20050032772
2005-02-10

Compounds useful as reversible inhibitors of cysteine proteases